A randomized, open-label, single-dose, four-period cross-over study to determine the effects of alcohol on the pharmacokinetics of carvedilol CR

Trial Profile

A randomized, open-label, single-dose, four-period cross-over study to determine the effects of alcohol on the pharmacokinetics of carvedilol CR

Completed
Phase of Trial: Phase I

Latest Information Update: 21 Sep 2012

At a glance

  • Drugs Carvedilol (Primary)
  • Indications Angina pectoris; Heart failure; Hypertension; Post-traumatic stress disorders
  • Focus Pharmacokinetics
  • Sponsors GlaxoSmithKline
  • Most Recent Events

    • 07 Feb 2007 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top